Show simple item record

dc.contributor.authorMoody, Catherine L.*
dc.contributor.authorWheelhouse, Richard T.*
dc.date.accessioned2015-06-08T13:06:39Z
dc.date.available2015-06-08T13:06:39Z
dc.date.issued2014-07-10
dc.identifier.citationMoody CL and Wheelhouse RT (2014) The Medicinal Chemistry of Imidazotetrazine Prodrugs. Pharmaceuticals. 7(7): 797-838.en_US
dc.identifier.urihttp://hdl.handle.net/10454/7236
dc.descriptionYesen_US
dc.description.abstractTemozolomide (TMZ) is the standard first line treatment for malignant glioma, reaching “blockbuster” status in 2010, yet it remains the only drug in its class. The main constraints on the clinical effectiveness of TMZ therapy are its requirement for active DNA mismatch repair (MMR) proteins for activity, and inherent resistance through O6-methyl guanine-DNA methyl transferase (MGMT) activity. Moreover, acquired resistance, due to MMR mutation, results in aggressive TMZ-resistant tumour regrowth following good initial responses. Much of the attraction in TMZ as a drug lies in its PK/PD properties: it is acid stable and has 100% oral bioavailability; it also has excellent distribution properties, crosses the blood-brain barrier, and there is direct evidence of tumour localisation. This review seeks to unravel some of the mysteries of the imidazotetrazine class of compounds to which TMZ belongs. In addition to an overview of different synthetic strategies, we explore the somewhat unusual chemical reactivity of the imidazotetrazines, probing their mechanisms of reaction, examining which attributes are required for an active drug molecule and reviewing the use of this combined knowledge towards the development of new and improved anti-cancer agents.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://dx.doi.org/10.3390/ph7070797en_US
dc.rights© 2014 Multidisciplinary Digital Publishing Institute. This is an Open Access article distributed under the Creative Commons Attribution License (CC-BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.subjectAzolotetrazinone; Temozolomide; Mitozolomide; MGMT; DNA mismatch repair; DNA alkylationen_US
dc.titleThe Medicinal Chemistry of Imidazotetrazine Prodrugsen_US
dc.status.refereedYesen_US
dc.date.Accepted2014-06-18
dc.typeArticleen_US
dc.type.versionpublished version paperen_US
refterms.dateFOA2018-07-25T11:30:25Z


Item file(s)

Thumbnail
Name:
wheelhouse_medicinal_chemistry ...
Size:
2.098Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record